West Pharmaceutical Services (WST) EBT (2009 - 2026)

West Pharmaceutical Services has disclosed EBT across 18 years of filings, most recently posting $180.1 million for Q2 2026.

• In Q2 2026, EBT rose 14.71% year-over-year to $180.1 million; the TTM figure through Jun 2026 stood at $693.6 million (up 16.2% YoY), while the FY2025 annual figure was $600.9 million, up 2.63% from the prior year.
• EBT came in at $180.1 million for Q2 2026 at West Pharmaceutical Services, roughly flat from $180.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $227.2 million in Q2 2022 to a low of $110.5 million in Q1 2025.
• Average EBT over 5 years is $162.5 million, with a median of $164.7 million recorded in 2024.
• Year-over-year, EBT sank 30.39% in 2024 and soared 62.99% in 2026.
• Over 5 years, EBT stood at $128.7 million in 2022, then jumped by 30.69% to $168.2 million in 2023, then slipped by 1.96% to $164.9 million in 2024, then decreased by 2.06% to $161.5 million in 2025, then gained by 11.52% to $180.1 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $180.1 million in Q2 2026, $180.1 million in Q1 2026, and $161.5 million in Q4 2025.